3 May 2022

Jeffreys Henry replaces EY as Top 9 Auditors on AIM

We are delighted to announce that Jeffrey Henry has replaced EY as Top 9 Auditors in the latest league table of auditors ranked by the number of AIM clients.
1 April 2022

Restaurant Directors’ Club – May 2022

The Restaurant Director's Club, hosted by accountancy firm Jeffreys Henry, is an exclusive, invite-only networking event that brings together a cross-section of leading restaurant and hospitality directors and industry experts.
23 March 2022

Spring Statement 2022 – Key Points

Chancellor Rishi Sunak will deliver his Spring Statement in Parliament at 12.30pm on Wednesday 23rd March 2022.
22 March 2022

Jeffreys Henry partners with Arram Berlyn Gardner (ABG)

We are thrilled to announce that Jeffreys Henry is joining forces with Arram Berlyn Gardner (ABG), marking a critical step in our strategy to partner with high-quality firms which enhance its offering to SMEs.
11 November 2021

HMRC Issue Nudge Letters to Cryptocurrency Investors

5 November 2021

Restaurant Directors’ Club – December 2021

27 October 2021

Autumn Budget 2021 – Read the Key Points and Announcements

The Chancellor, Rishi Sunak, has delivered the 2021 Autumn Budget on 27 October 2021. Our specialist Personal and Corporate Tax Teams have summarised the key announcements below, with a full report to be published on Thursday 28 October 2021.
22 October 2021

Specialist Team of the Year 2021 🏆

We are thrilled to announce that Jeffreys Henry have once again WON one of the most hotly contested trophies in the accountancy profession: Specialist Team of the Year 2021. The awards, hosted by Accounting Excellence, are regarded as the industry’s most prestigious accolade with a panel of senior industry figures taking part in a multi-stage process to find the most innovative and best-performing practices.
20 July 2021

Jeffreys Henry advise Poolbeg Pharma Plc on £50m AIM IPO

Poolbeg Pharma, a spin out of Open Orphan, has successfully raised £25 million (before expenses) and lists with a market capitalisation of £50 million. Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company. Their novel capital light clinical model enables them to develop multiple products faster and more cost effectively than the traditional biotech model.